Regeneron Pharmaceuticals, Inc.

Hudson Bay Capital Management LP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

26,127

Value ($000)

20,167

Weight

0.1%

2019 Q4 - 2025 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	20,167	0.1%	26,127	12/31/2025
2025 Q3	12/15/2025	19,000	0.1%	33,791	9/30/2025
2025 Q2	8/18/2025	34,838	0.2%	66,358	6/30/2025
2025 Q1	5/14/2025	13,057	0.1%	20,587	3/31/2025
2024 Q4	2/14/2025	10,689	0.1%	15,006	12/31/2024
2024 Q3	11/13/2024	30,856	0.2%	29,352	9/30/2024
2024 Q2	8/14/2024	16,877	0.1%	16,058	6/30/2024
2023 Q4	2/14/2024	36,449	0.3%	41,500	12/31/2023
2023 Q2	8/14/2023	431	0.0%	600	6/30/2023
2022 Q4	2/14/2023	9,668	0.1%	13,400	12/31/2022
2021 Q1	5/14/2021	17,979	0.3%	38,000	3/31/2021
2020 Q4	2/12/2021	18,600	0.2%	38,500	12/31/2020
2019 Q4	2/12/2020	11,264	0.3%	30,000	12/31/2019